[English] 日本語
Yorodumi Papers
- Database of articles cited by EMDB/PDB/SASBDB data -

+
Search query

Keywords
Structure methods
Author
Journal
IF

-
Structure paper

TitleHuman broadly neutralizing influenza B virus antibodies recognizing hemagglutinin computationally optimized broadly reactive antigens.
Journal, issue, pagesFront Immunol, Vol. 17, Page 1747235, Year 2026
Publish dateMar 25, 2026
AuthorsYailin Campos Mota / John V Dzimianski / Mariana Lopez / Robert A Richardson / Ted M Ross / Ian J A Kunkel / Sara M O'Rourke / Vitor Hugo Balasco Serrão / Rebecca M DuBois / Giuseppe A Sautto /
PubMed AbstractINTRODUCTION: Influenza B viruses (IBVs) are responsible for severe disease and death, similarly to influenza A viruses (IAVs), with a higher number of infections happening in children and the ...INTRODUCTION: Influenza B viruses (IBVs) are responsible for severe disease and death, similarly to influenza A viruses (IAVs), with a higher number of infections happening in children and the elderly. Despite the inclusion of an IBV component in the seasonal influenza vaccine, rates of vaccine effectiveness (VE) are still variable and low in many previous seasons.
METHODS: In this work, longitudinal profiling of IBV hemagglutinin (HA)-specific B-cell responses was described following influenza vaccination in 15 vaccinated participants over four consecutive influenza seasons. These individuals belonged to different age groups and monoclonal antibodies (mAbs) showing broad binding and functional antibody profiles were isolated from the plasmablasts of one individual.
RESULTS: These individuals possessed different breadths and magnitudes of antibody responses to a panel of IBV historical and more recent vaccine strains. In particular, young adults (age 23-33) showed a higher magnitude and breadth of antibody response compared to middle-aged (age 55-58) and elderly (age 65-77) participants who instead showed a lower albeit detectable antibody response. Interestingly, one of the isolated mAbs, mAb #46, had the broadest response with a broad binding and potent functional activity against historical and recent IBV strains spanning both Victoria and Yamagata lineages and including binding to IBV computationally optimized broadly reactive antigen (COBRA) HAs. Importantly, mAb #46 administration, either therapeutically or prophylactically, fully protected IBV-challenged mice. Structural characterization of the mAb #46-HA complex by cryo-electron microscopy single-particle analysis revealed that mAb #46 targets a conserved epitope within the HA receptor binding site.
DISCUSSION: This study highlights the presence of broadly neutralizing antibodies in the human repertoire that may be recalled by vaccination with COBRA HA, although this hypothesis will be confirmed in upcoming clinical trials.
External linksFront Immunol / PubMed:41958660 / PubMed Central
MethodsEM (single particle)
Resolution2.5 Å
Structure data

49477

9nja

EMDB-49477, PDB-9nja:
Computationally optimized broadly reactive influenza B hemagglutinin BC2 bound by antibody #46
Method: EM (single particle) / Resolution: 2.5 Å

Chemicals

ChemComp-NAG:
2-acetamido-2-deoxy-beta-D-glucopyranose

Source
  • homo sapiens (human)
  • influenza b virus
KeywordsVIRAL PROTEIN/Immune System / influenza / antibody / cell entry / hemagglutination / VIRAL PROTEIN / VIRAL PROTEIN-Immune System complex

+
About Yorodumi Papers

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi Papers

Database of articles cited by EMDB/PDB/SASBDB data

  • Database of articles cited by EMDB, PDB, and SASBDB entries
  • Using PubMed data

Related info.:EMDB / PDB / SASBDB / Yorodumi / EMN Papers / Changes in new EM Navigator and Yorodumi

Read more